NF-κB Reporter (Luc) - HCT116 Recombinant Cell Line

Catalog #
60623
$1,095 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The NF-κB reporter (Luc)-HCT-116 cell line is designed to monitor nuclear factor Kappa B (NF-κB) signal transduction pathways. It contains a firefly luciferase gene driven by four copies of the NF-κB response element located upstream of the minimal TATA promoter. After activation by pro-inflammatory cytokines or agonists of lymphokine receptors, endogenous NF-κB transcription factors bind to the DNA response elements, inducing transcription of the luciferase reporter gene.

Interested in screening and profiling inhibitors, blocking antibodies, or activators of NF-κB-mediated signaling without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
NF-κB cell line, NFkappaB cell line, luciferase reporter, NF-kB cell line, NFkB cell line, nfkb, nf-kb
Product Info
Storage and Usage
Citations
Host Cell Line
HCT-116
Supplied As
Each vial contains ~2 X 106 cells in 1 ml of 90% FBS, 10% DMSO
Materials Required But Not Supplied

Materials Required for Cell Culture

Name Ordering Information
Thaw Medium 7 BPS Bioscience #60185
Growth Medium 7A BPS Bioscience #79543


Materials Required for Cellular Assay

Name Ordering Information
hTNFα R&D Systems #210-TA
Assay Medium: Thaw Medium 7 BPS Bioscience #60185
IKK-16 dihydrochloride: inhibitor of NF-κB activation Sigma #SML1138
96-well tissue culture-treated white clear-bottom assay plate Corning #3610
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
Format
Aqueous solution containing DMSO
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

References

1. Samuel T et.al. (2014) Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs. BMC Cancer 14: 599.
2. Arabi A et.al. (2012) Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway. Nature Communication
3: 976. 3. Clemo NK et.al. (2008) BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-κB activity. Carcinogenesis 29: 849.
4. Tukhvatulin AI et.al. (2011) An In Vitro and In Vivo Study of the ability of NOD1 Ligands to Activate the Transcriptional Factor NF-κB. Acta Naturae 3: 77.